By immunoprecipitating VEGFR2 from tumour lysates and probing with anti-phosphotyrosine followed by anti-VEGFR2 antibody via Western blot, we quantified total and activated VEGFR2 from whole tumour lysates6. This evidence concerns the gene KDR and neoplasm.